“…In vitro reconstitution experiments have shown that MCAK activity is significantly suppressed by α-tubulin detyrosination (Peris et al, 2009; Sirajuddin et al, 2014), a posttranslational modification that accumulates on long-lived MTs (Nieuwenhuis and Brummelkamp, 2019). α-tubulin detyrosination has been recently implicated in mitosis and meiosis, neuronal processes and cognitive brain function, heart and skeletal muscle contraction, and cancer (Akera et al, 2017; Barisic et al, 2015; Chen et al, 2018; Erck et al, 2005; Kerr et al, 2015; Lafanechère et al, 1998; Liao et al, 2019; Pagnamenta et al, 2019; Robison et al, 2016). The detyrosination/tyrosination cycle involves the catalytic removal of the C-terminal tyrosine of most mammalian α-tubulin isoforms by tubulin carboxypeptidases, such as the recently identified Vasohibin (VASH) 1/VASH2-SVBP complexes (Aillaud et al, 2017; Nieuwenhuis et al, 2017), followed by retyrosination of soluble α-tubulin by tubulin tyrosine ligase (TTL; Ersfeld et al, 1993).…”